Symbol:
Nkain2
Name:
sodium/potassium transporting ATPase interacting 2
RGD ID:
7740967
Description:
Predicted to be involved in regulation of sodium ion transport. Predicted to be located in plasma membrane. Human ortholog(s) of this gene implicated in alcohol dependence and cognitive disorder. Orthologous to human NKAIN2 (sodium/potassium transporting ATPase interacting 2); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran; N,N-diethyl-m-toluamide.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC102551716; Na+/K+ transporting ATPase interacting 2; NKAIN2 transcript-like; sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2; sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2-like
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 26,488,381 - 27,696,134 (+) NCBI GRCr8 mRatBN7.2 1 24,668,627 - 25,877,051 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 24,669,462 - 25,877,064 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 1 27,473,251 - 28,161,521 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 27,476,375 - 28,159,290 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 28,926,594 - 29,615,541 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Celera 1 23,895,595 - 24,572,547 (+) NCBI Celera Cytogenetic Map 1 p11 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Nkain2 Rat 1,2-dichloroethane increases expression ISO Nkain2 (Mus musculus) 6480464 ethylene dichloride results in increased expression of NKAIN2 mRNA CTD PMID:28960355 Nkain2 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Nkain2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Nkain2 Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Nkain2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Nkain2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Nkain2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NKAIN2 mRNA CTD PMID:21570461 Nkain2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NKAIN2 mRNA CTD PMID:32109520 Nkain2 Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Nkain2 Rat aflatoxin B1 decreases methylation ISO NKAIN2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of NKAIN2 gene CTD PMID:27153756 Nkain2 Rat aflatoxin B1 increases methylation ISO NKAIN2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of NKAIN2 intron CTD PMID:30157460 Nkain2 Rat Aflatoxin B2 alpha decreases methylation ISO NKAIN2 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of NKAIN2 intron CTD PMID:30157460 Nkain2 Rat all-trans-retinoic acid increases expression ISO NKAIN2 (Homo sapiens) 6480464 Tretinoin results in increased expression of NKAIN2 mRNA CTD PMID:21934132 Nkain2 Rat all-trans-retinoic acid increases expression ISO Nkain2 (Mus musculus) 6480464 Tretinoin results in increased expression of NKAIN2 mRNA CTD PMID:36189433 Nkain2 Rat all-trans-retinoic acid multiple interactions ISO Nkain2 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NKAIN2 mRNA CTD PMID:36189433 Nkain2 Rat arsane affects methylation ISO NKAIN2 (Homo sapiens) 6480464 Arsenic affects the methylation of NKAIN2 gene CTD PMID:25304211 Nkain2 Rat arsenic atom affects methylation ISO NKAIN2 (Homo sapiens) 6480464 Arsenic affects the methylation of NKAIN2 gene CTD PMID:25304211 Nkain2 Rat benzo[a]pyrene decreases expression ISO NKAIN2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of NKAIN2 mRNA CTD PMID:20106945 and PMID:21871943 Nkain2 Rat benzo[a]pyrene affects methylation ISO NKAIN2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of NKAIN2 intron CTD PMID:30157460 Nkain2 Rat benzo[a]pyrene decreases methylation ISO NKAIN2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of NKAIN2 3' UTR CTD PMID:27901495 Nkain2 Rat benzo[a]pyrene increases methylation ISO NKAIN2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of NKAIN2 5' UTR and Benzo(a)pyrene results in increased methylation of NKAIN2 promoter CTD PMID:27901495 Nkain2 Rat benzo[e]pyrene decreases methylation ISO NKAIN2 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of NKAIN2 intron CTD PMID:30157460 Nkain2 Rat bisphenol A affects methylation ISO NKAIN2 (Homo sapiens) 6480464 bisphenol A affects the methylation of NKAIN2 gene CTD PMID:31601247 Nkain2 Rat chlorpyrifos increases expression ISO Nkain2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of NKAIN2 mRNA CTD PMID:37019170 Nkain2 Rat cyclosporin A increases expression ISO NKAIN2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of NKAIN2 mRNA CTD PMID:20106945 Nkain2 Rat dorsomorphin multiple interactions ISO NKAIN2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NKAIN2 mRNA CTD PMID:27188386 Nkain2 Rat methapyrilene decreases methylation ISO NKAIN2 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of NKAIN2 intron CTD PMID:30157460 Nkain2 Rat mono(2-ethylhexyl) phthalate multiple interactions ISO Nkain2 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NKAIN2 mRNA CTD PMID:36189433 Nkain2 Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of NKAIN2 gene CTD PMID:33148267 Nkain2 Rat N-methyl-4-phenylpyridinium decreases expression ISO NKAIN2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of NKAIN2 mRNA CTD PMID:24810058 Nkain2 Rat nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of NKAIN2 mRNA CTD PMID:33484710 Nkain2 Rat O-methyleugenol decreases expression ISO NKAIN2 (Homo sapiens) 6480464 methyleugenol results in decreased expression of NKAIN2 mRNA CTD PMID:32234424 Nkain2 Rat paracetamol increases expression ISO NKAIN2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of NKAIN2 mRNA CTD PMID:26690555 Nkain2 Rat PCB138 multiple interactions ISO Nkain2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Nkain2 Rat permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of NKAIN2 gene CTD PMID:33148267 Nkain2 Rat SB 431542 multiple interactions ISO NKAIN2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NKAIN2 mRNA CTD PMID:27188386 Nkain2 Rat sodium arsenite decreases expression ISO Nkain2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of NKAIN2 mRNA CTD PMID:36209798 Nkain2 Rat sunitinib increases expression ISO NKAIN2 (Homo sapiens) 6480464 Sunitinib results in increased expression of NKAIN2 mRNA CTD PMID:31533062 Nkain2 Rat thimerosal decreases expression ISO Nkain2 (Mus musculus) 6480464 Thimerosal results in decreased expression of NKAIN2 mRNA CTD PMID:24675092 Nkain2 Rat titanium dioxide increases methylation ISO Nkain2 (Mus musculus) 6480464 titanium dioxide results in increased methylation of NKAIN2 gene CTD PMID:35295148 Nkain2 Rat titanium dioxide decreases methylation ISO Nkain2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of NKAIN2 promoter CTD PMID:35295148 Nkain2 Rat triclosan decreases expression ISO NKAIN2 (Homo sapiens) 6480464 Triclosan results in decreased expression of NKAIN2 mRNA CTD PMID:30510588 Nkain2 Rat valproic acid affects expression ISO NKAIN2 (Homo sapiens) 6480464 Valproic Acid affects the expression of NKAIN2 mRNA CTD PMID:25979313 Nkain2 Rat valproic acid increases expression ISO NKAIN2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of NKAIN2 mRNA CTD PMID:24383497 and PMID:26272509 Nkain2 Rat valproic acid decreases expression ISO Nkain2 (Mus musculus) 6480464 Valproic Acid results in decreased expression of NKAIN2 mRNA CTD PMID:24896083 Nkain2 Rat valproic acid decreases expression ISO NKAIN2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of NKAIN2 mRNA CTD PMID:27188386 Nkain2 Rat valproic acid multiple interactions ISO NKAIN2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NKAIN2 mRNA CTD PMID:27188386
1,2-dichloroethane (ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) arsane (ISO) arsenic atom (ISO) benzo[a]pyrene (ISO) benzo[e]pyrene (ISO) bisphenol A (ISO) chlorpyrifos (ISO) cyclosporin A (ISO) dorsomorphin (ISO) methapyrilene (ISO) mono(2-ethylhexyl) phthalate (ISO) N,N-diethyl-m-toluamide (EXP) N-methyl-4-phenylpyridinium (ISO) nitrofen (EXP) O-methyleugenol (ISO) paracetamol (ISO) PCB138 (ISO) permethrin (EXP) SB 431542 (ISO) sodium arsenite (ISO) sunitinib (ISO) thimerosal (ISO) titanium dioxide (ISO) triclosan (ISO) valproic acid (ISO)
1.
Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders.
Blokland GAM, etal., Biol Psychiatry. 2022 Jan 1;91(1):102-117. doi: 10.1016/j.biopsych.2021.02.972. Epub 2021 Mar 23.
2.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
3.
NKAIN2 functions as a novel tumor suppressor in prostate cancer.
Mao X, etal., Oncotarget. 2016 Sep 27;7(39):63793-63803. doi: 10.18632/oncotarget.11690.
4.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
5.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
6.
High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.
Romania P, etal., PLoS One. 2013 Oct 25;8(10):e78481. doi: 10.1371/journal.pone.0078481. eCollection 2013.
7.
Family-based association analysis of alcohol dependence in the COGA sample and replication in the Australian twin-family study.
Wang KS, etal., J Neural Transm (Vienna). 2011 Sep;118(9):1293-9. doi: 10.1007/s00702-011-0628-3. Epub 2011 Mar 29.
Nkain2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 26,488,381 - 27,696,134 (+) NCBI GRCr8 mRatBN7.2 1 24,668,627 - 25,877,051 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 24,669,462 - 25,877,064 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 1 27,473,251 - 28,161,521 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 27,476,375 - 28,159,290 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 28,926,594 - 29,615,541 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Celera 1 23,895,595 - 24,572,547 (+) NCBI Celera Cytogenetic Map 1 p11 NCBI
NKAIN2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 6 123,803,865 - 124,825,640 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 6 123,803,865 - 124,825,640 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 6 124,125,010 - 125,146,786 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 6 124,166,768 - 125,188,485 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 6 124,166,987 - 125,188,485 NCBI Celera 6 124,869,958 - 125,891,802 (+) NCBI Celera Cytogenetic Map 6 q22.31 NCBI HuRef 6 121,702,429 - 122,723,736 (+) NCBI HuRef CHM1_1 6 124,388,612 - 125,410,248 (+) NCBI CHM1_1 T2T-CHM13v2.0 6 124,991,747 - 126,013,690 (+) NCBI T2T-CHM13v2.0
Nkain2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 10 31,565,314 - 32,773,170 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 10 31,565,306 - 32,766,458 (-) Ensembl GRCm39 Ensembl GRCm38 10 31,689,310 - 32,897,174 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 10 31,689,310 - 32,890,462 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 10 31,409,125 - 32,609,721 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 10 31,378,735 - 32,579,264 (-) NCBI MGSCv36 mm8 Celera 10 32,612,553 - 33,799,322 (-) NCBI Celera Cytogenetic Map 10 A4 NCBI cM Map 10 17.56 NCBI
Nkain2 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955436 5,407,773 - 6,343,953 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955436 5,407,642 - 6,345,015 (+) NCBI ChiLan1.0 ChiLan1.0
NKAIN2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 5 143,793,042 - 144,817,344 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 6 141,700,135 - 142,776,468 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 6 121,590,732 - 122,611,445 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 6 125,713,030 - 126,732,080 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 6 125,713,247 - 126,729,668 (+) Ensembl panpan1.1 panPan2
NKAIN2 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 1 63,091,956 - 63,857,512 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 1 62,910,841 - 63,858,164 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 1 63,719,503 - 64,668,404 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 1 63,115,179 - 64,065,713 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 1 63,115,326 - 64,065,725 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 1 63,047,299 - 63,997,590 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 1 62,836,039 - 63,786,131 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 1 63,484,826 - 64,435,218 (+) NCBI UU_Cfam_GSD_1.0
NKAIN2 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 38,014,255 - 39,040,605 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 38,014,252 - 39,040,215 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 42,053,739 - 42,198,706 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
NKAIN2
Nkain2
.
Assembly: mRatBN7.2
Chromosome Start Pos End Pos Reference Nucleotide Variant Nucleotide Variant Type Strain Variant Page
1
25336695
25336696
G
A
snv
European Variation Archive Release 3 , European Variation Archive Release 4, European Variation Archive Release 6, SHR/OlalpcvMcwi (2019NG), BXH3/CubMcwi (2020), HXB10/IpcvMcwi (2019), SHR/NHsd (2021), HXB4/IpcvMcwi (2020), SHRSP/A3NCrl (2019), SHR/OlalpcvMcwi (2019), BXH6/CubMcwi (2021), SHRSP/A3NCrl (2019NG), SHR/NCrl (2021), HXB2/IpcvMcwi (2019) View more Information
Predicted Target Of
Count of predictions: 17 Count of miRNA genes: 17 Interacting mature miRNAs: 17 Transcripts: ENSRNOT00000047224 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
631688 Hcas2 Hepatocarcinoma susceptibility QTL 2 3 0.0001 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 5925874 115540829 Rat 1357397 Bw41 Body weight QTL 41 4.19 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 1 22340647 49361612 Rat 1578650 Bmd6 Bone mineral density QTL 6 12.2 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 1 509108 43284926 Rat 1354647 Despr8 Despair related QTL 8 0.0000341 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 1 1 24744506 Rat 1578651 Bmd7 Bone mineral density QTL 7 14.2 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 1 509108 43284926 Rat 2313062 Bmd73 Bone mineral density QTL 73 3.9 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 11481312 82174945 Rat 1554320 Bmd1 Bone mineral density QTL 1 12.2 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 509108 86060548 Rat 2313065 Bss67 Bone structure and strength QTL 67 3.1 0.0001 tibia area (VT:1000281) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 7421626 Bp360 Blood pressure QTL 360 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 4393289 49393289 Rat 1357400 Bw62 Body weight QTL62 4.05 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 1 22340647 67340647 Rat 2313070 Bss52 Bone structure and strength QTL 52 4.4 0.0001 body length (VT:0001256) body length (CMO:0000013) 1 1 32356093 Rat 1357401 Bw43 Body weight QTL 43 3.75 body mass (VT:0001259) body weight (CMO:0000012) 1 22340647 49361612 Rat 2313069 Bss68 Bone structure and strength QTL 68 2.9 0.0001 tibia size trait (VT:0100001) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 631495 Bp96 Blood pressure QTL 96 4.52 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 22340647 102268831 Rat 631494 Bp95 Blood pressure QTL 95 40 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 16206210 49268520 Rat 2313075 Bss66 Bone structure and strength QTL 66 3.4 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 11481312 82174945 Rat 5684998 Bss101 Bone structure and strength QTL 101 3.6 tibia strength trait (VT:1000284) tibia ultimate force (CMO:0001734) 1 15431621 49361612 Rat 2298546 Neuinf4 Neuroinflammation QTL 4 5.1 nervous system integrity trait (VT:0010566) spinal cord RT1-B protein level (CMO:0002132) 1 1 28736750 Rat 5684999 Bss102 Bone structure and strength QTL 102 5.5 7e-07 tibia strength trait (VT:1000284) tibia stiffness (CMO:0001735) 1 15431621 49361612 Rat 1300167 Hrtrt2 Heart rate QTL 2 4.35 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 11481312 75088344 Rat 2313077 Bss69 Bone structure and strength QTL 69 3.5 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 1 11481312 82174945 Rat 2317755 Glom22 Glomerulus QTL 22 3.8 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 1 11481482 32355910 Rat 1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 2.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 11835181 56835181 Rat 631508 Sald1 Serum aldosterone level QTL 1 3.7 blood aldosterone amount (VT:0005346) serum aldosterone level (CMO:0000487) 1 9856001 54856001 Rat 2313090 Bmd69 Bone mineral density QTL 69 4.4 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 1 32356093 Rat 4889451 Eae29 Experimental allergic encephalomyelitis QTL 29 5.51 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis severity score (CMO:0001419) 1 5925877 24697545 Rat 724520 Bp145 Blood pressure QTL 145 2.1 0.0024 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 20784828 65784828 Rat 1558642 Prcr2 Prostate cancer resistance QTL 2 4.3 prostate integrity trait (VT:0010571) area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) 1 20763158 44095856 Rat 2313092 Bmd72 Bone mineral density QTL 72 2.5 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 1 11481312 82174945 Rat 2313097 Bss70 Bone structure and strength QTL 70 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 738020 Pia8 Pristane induced arthritis QTL 8 4.7 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 1 1 65833076 Rat 1600360 Mcs16 Mammary carcinoma susceptibility QTL 16 2.4 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 1 2244390 43433040 Rat 1578669 Bss9 Bone structure and strength QTL 9 6.3 femur morphology trait (VT:0000559) bone trabecular cross-sectional area (CMO:0002311) 1 509108 43284926 Rat 2302038 Pia31 Pristane induced arthritis QTL 31 5.5 0.001 blood autoantibody amount (VT:0003725) serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) 1 10992065 55992065 Rat 634353 Rends2 Renal damage susceptibility QTL 2 0.05 kidney blood vessel morphology trait (VT:0000530) organ lesion measurement (CMO:0000677) 1 19333571 56983283 Rat 2313053 Bss51 Bone structure and strength QTL 51 3.8 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 1 32356093 Rat
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
7
8
37
112
54
52
23
16
23
6
137
73
93
27
55
29
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000047224 ⟹ ENSRNOP00000047346
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 24,669,462 - 25,877,064 (+) Ensembl Rnor_6.0 Ensembl 1 27,476,375 - 28,155,831 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000075427 ⟹ ENSRNOP00000067471
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 24,669,462 - 25,877,064 (+) Ensembl Rnor_6.0 Ensembl 1 27,476,375 - 28,159,290 (+) Ensembl
RefSeq Acc Id:
XM_063276503 ⟹ XP_063132573
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 26,488,411 - 27,691,143 (+) NCBI
RefSeq Acc Id:
XM_063276506 ⟹ XP_063132576
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 26,488,396 - 27,696,134 (+) NCBI
RefSeq Acc Id:
XM_063276515 ⟹ XP_063132585
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 26,488,388 - 27,696,134 (+) NCBI
RefSeq Acc Id:
XR_005499794
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 26,488,412 - 27,696,134 (+) NCBI mRatBN7.2 1 24,669,286 - 25,877,051 (+) NCBI
RefSeq Acc Id:
XR_010058891
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 26,488,381 - 27,696,134 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000067471 ⟸ ENSRNOT00000075427
Ensembl Acc Id:
ENSRNOP00000047346 ⟸ ENSRNOT00000047224
RefSeq Acc Id:
XP_063132585 ⟸ XM_063276515
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_063132576 ⟸ XM_063276506
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_063132573 ⟸ XM_063276503
- Peptide Label:
isoform X1
- UniProtKB:
M0RCY3 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2018-04-09
Nkain2
sodium/potassium transporting ATPase interacting 2
LOC102551716
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2-like
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2018-04-09
LOC102551716
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2-like
Nkain2
Na+/K+ transporting ATPase interacting 2
Data merged from RGD:2323702
737654 PROVISIONAL
2013-12-18
LOC102551716
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2-like
Symbol and Name status set to provisional
70820 PROVISIONAL
2012-08-30
Nkain2
Na+/K+ transporting ATPase interacting 2
LOC100362992
NKAIN2 transcript-like
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2010-05-06
LOC100362992
NKAIN2 transcript-like
Symbol and Name status set to provisional
70820 PROVISIONAL
